Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Neuromodulation Devices Companies

Neuromodulation devices companies specialize in the development and manufacturing of medical devices designed to modulate the nervous system's activity for therapeutic purposes. These devices are used in the treatment of various neurological and psychiatric disorders.

Neuromodulation Devices Key Companies

Latest Neuromodulation Devices Companies Update

December 2023, Medtronic, a global medical technology leader, acquired Nfocus Neuro, a pioneering company developing closed-loop deep brain stimulation (DBS) technology for

Parkinson's disease and other neurological disorders. This acquisition strengthens Medtronic's position in the neuromodulation market and paves the way for more personalized and effective DBS therapies.

Abbott, another major player in the market, launched its Proclaim Plus SCS System in September 2023. This advanced spinal cord stimulator features wireless recharge and MRI compatibility, offering greater convenience and flexibility for patients with chronic pain.

Boston Scientific received FDA approval in October 2023 for the use of its VNS Therapy System (vagus nerve stimulation) for treatment-resistant depression. This marks a significant milestone in the field of neuromodulation and offers new hope for patients struggling with this debilitating condition.

List of Neuromodulation Devices Key Companies in the Market

Nevro Corporation (U.S.)

LivaNova PLC (UK)

Boston Scientific Corporation (US)

Aleva Neurotherapeutics SA (US)

Bioness Inc. (US)

EnteroMedics Inc (US)

Neuronetics Inc. (US)

Cyberonics Inc. (US)

Jude Medical Inc. (U.S.)

Accellent (US)

DynaMD (US)

Neuromodulation Devices Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.